Kari Gillmeyer, MD, MSc
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Pulmonary, Allergy, Sleep & Critical Care Medicine

MD, University of Minnesota Medical School
BS, South Dakota State University

Pronouns: she/her/hers



Dr. Gillmeyer is a health services researcher with a career dedicated to improving quality of care and outcomes for vulnerable patients. Dr. Gillmeyer’s work focuses on pulmonary hypertension, a devastating, progressive disease that exerts a heavy burden on patients and health systems. Through her research, Dr. Gillmeyer hopes to improve the quality, safety, and equity of pulmonary hypertension care and to mitigate health disparities in pulmonary hypertension.

Member
Boston University
Pulmonary Center




Characterizing Care Coordination in Pulmonary Hypertension: A Mixed Methods Study
07/01/2021 - 06/30/2024 (PI)
Parker B. Francis Fellowship Program


Determining disparities in treatment of pulmonary arterial hypertension nationally
09/01/2019 - 08/31/2021 (PI)
NIH/National Heart, Lung, and Blood Institute
5F32HL149236-02



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG. Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group. Pulm Circ. 2023 Oct; 13(4):e12317. PMID: 38144948; PMCID: PMC10739115; DOI: 10.1002/pul2.12317;
     
  2. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Clinical Decision Tool for Risk Stratifying Patients with Systemic Sclerosis-Related Pulmonary Hypertension. Lung. 2023 Dec; 201(6):565-569.View Related Profiles. PMID: 37957388; DOI: 10.1007/s00408-023-00646-2;
     
  3. Pang B, Kearney L, Maccarone J, Zhang J, Kearney C, Sangani R, Shankar DA, Gillmeyer KR, Law AC, Bosch NA. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia. Ann Am Thorac Soc. 2023 Jun; 20(6):917-920.View Related Profiles. PMID: 36867519; PMCID: PMC10257036; DOI: 10.1513/AnnalsATS.202210-847RL;
     
  4. Li B, Gillmeyer KR, Molloy-Paolillo B, Vimalananda VG, Elwy AR, Wiener RS, Rinne ST. Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps. Ann Am Thorac Soc. 2023 Mar; 20(3):456-465.View Related Profiles. PMID: 36490386; PMCID: PMC9993154; DOI: 10.1513/AnnalsATS.202205-404OC;
     
  5. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20.View Related Profiles. PMID: 36662449
     
  6. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 Jul; 75(7):1462-1468.View Related Profiles. PMID: 35678779; PMCID: PMC9732142; DOI: 10.1002/acr.24969;
     
  7. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06.View Related Profiles. PMID: 36607535; PMCID: PMC10666735; DOI: 10.1007/s10557-022-07420-1;
     
  8. Gillmeyer KR, Johnson SW, Bolton RE, McCullough MB, Wiener RS. Organization of pulmonary hypertension care in non-expert care settings: Lessons learned from a multi-site study. Health Serv Res. 2023 Jun; 58(3):663-673.View Related Profiles. PMID: 36518045; PMCID: PMC10154164; DOI: 10.1111/1475-6773.14114;
     
  9. Sangani RA, Lui JK, Gillmeyer KR, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. Pulm Circ. 2022 Oct; 12(4):e12117.View Related Profiles. PMID: 36238967; PMCID: PMC9535436; DOI: 10.1002/pul2.12117;
     
  10. Gillmeyer KR, Rinne ST, Qian SX, Maron BA, Johnson SW, Klings ES, Wiener RS. Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12(4):e12171.View Related Profiles. PMID: 36568691; PMCID: PMC9768567; DOI: 10.1002/pul2.12171;
     
Showing 10 of 22 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 22 publications over 6 distinct years, with a maximum of 7 publications in 2023

YearPublications
20181
20192
20204
20212
20226
20237

2021-2024 Parker B Francis Fellowship Award
2019-2021 F32 HL149236-01: Determining disparities in treatment of pulmonary arterial hypertension nationally
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Pulmonary hypertension
Health disparities
Care organization
Care delivery
Health services research
Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map


Gillmeyer's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department